A novel class of selective ERα degraders acts as full antagonists/ inverse agonists and displays efficacy in pre-clinical models of endocrine-resistant breast cancer and endometrial cancer

被引:0
|
作者
Darimont, Beatrice
Lu, Ninh
Sensintaffar, John
Lee, Kyoung-Jin
Aparicio, Anna
Kaufman, Joshua
Bischoff, Eric
Rix, Peter
Heyman, Rich
Smith, Nicholas
Hager, Jeffrey
Joseph, James
Grillot, Katherine
Qian, Jing
Gang, Shao
Govek, Steven
Nagasawa, Johnny
Lai, Andiliy
Kahraman, Mehmet
机构
关键词
D O I
10.1158/1078-0432.MECHRES-A4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A4
引用
收藏
页数:2
相关论文
共 11 条
  • [1] A novel class of selective estrogen receptors degraders regresses tumors in pre-clinical models of endocrine-resistant breast cancer
    Joseph, James D.
    Darimont, Beatrice
    Govek, Steven
    Brigham, Dan
    Qian, Jing
    Sensintaffar, John
    Shao, Gang
    Aparicio, Anna
    Kahraman, Mehmet
    Lai, Andiliy
    Lee, Kyoung-Jin
    Lu, Nhin
    Nagasawa, Johnny
    Moon, Michael
    Rix, Peter
    Smith, Nick
    Hager, Jeff
    CANCER RESEARCH, 2014, 74 (19)
  • [2] A novel class of selective estrogen receptors degraders regresses tumors in pre-clinical models of endocrine-resistant breast cancer
    Darimont, Beatrice
    Govek, Steven
    Lu, Nihn
    Nagasawa, Johnny
    Prudente, Rene
    Qian, Jing
    Sensintaffar, John
    Shao, Gang
    Heyman, Richard
    Rix, Peter
    Smith, Nicholas
    Hager, Jeffrey
    Joseph, James
    Grillot, Katherine
    Aparicio, Anna
    Bischoff, Eric
    Kahraman, Mehmet
    Kaufman, Josh
    Lai, Andiliy
    Lee, Kyoung-Jin
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [3] Novel selective estrogen receptors degraders regress tumors in pre-clinical models of endocrine-resistant breast cancer
    Hager, J. H.
    Darimont, B.
    Joseph, J.
    Govek, S.
    Grillot, K.
    Aparicio, A.
    Bischoff, E.
    Kahraman, M.
    Kaufman, J.
    Lai, A.
    Lee, K-J
    Lu, N.
    Nagasawa, J.
    Prudente, R.
    Qian, J.
    Sensintaffar, J.
    Shao, G.
    Heyman, R.
    Rix, P.
    Smith, N. D.
    CANCER RESEARCH, 2012, 72
  • [4] A novel class of selective estrogen receptor degraders display activity in pre-clinical models of ERα plus ovarian cancer
    Joseph, James D.
    Darimont, Beatrice
    Govek, Steven
    Brigham, Dan
    Aparicio, Anna
    Kahraman, Mehmet
    Lai, Andiliy
    Lu, Lee Nhin
    Nagasawa, Johnny
    Kaufman, Josh
    Moon, Michael
    Prudente, Rene
    Qian, Jing
    Sensintaffar, John
    Shao, Gang
    Rix, Peter
    Smith, Nick
    Hager, Jeff
    CLINICAL CANCER RESEARCH, 2013, 19
  • [5] Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
    Yubo Wang
    Jian Min
    Xiangping Deng
    Tian Feng
    Hebing Hu
    Xinyi Guo
    Yan Cheng
    Baohua Xie
    Yu Yang
    Chun-Chi Chen
    Rey-Ting Guo
    Chune Dong
    Hai-Bing Zhou
    Acta Pharmaceutica Sinica B, 2023, (12) : 4963 - 4982
  • [6] Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
    Wang, Yubo
    Min, Jian
    Deng, Xiangping
    Feng, Tian
    Hu, Hebing
    Guo, Xinyi
    Cheng, Yan
    Xie, Baohua
    Yang, Yu
    Chen, Chun-Chi
    Guo, Rey-Ting
    Dong, Chune
    Zhou, Hai-Bing
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (12) : 4963 - 4982
  • [7] Discovery of a Novel Class of PROTACs as Potent and Selective Estrogen Receptor α Degraders to Overcome Endocrine-Resistant Breast Cancer In Vitro and In Vivo
    Xie, Baohua
    Yin, Zhinang
    Hu, Zhiye
    Lv, Junhui
    Du, Chuanqian
    Deng, Xiangping
    Huang, Yuan
    Li, Qiuzi
    Huang, Jian
    Liang, Kaiwei
    Zhou, Hai-Bing
    Dong, Chune
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (10) : 6631 - 6651
  • [8] Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer
    Xin, Lilan
    Wang, Chao
    Cheng, Yan
    Wang, Hongli
    Guo, Xinyi
    Deng, Xiaofei
    Deng, Xiangping
    Xie, Baohua
    Hu, Hankun
    Min, Chang
    Dong, Chune
    Zhou, Hai-Bing
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 8913 - 8931
  • [9] Discovery of Thiochroman Derivatives as Potent, Oral Selective Estrogen Receptor Degraders and Antagonists for the Treatment of Endocrine-Resistant Breast Cancer
    Zhang, Dan
    Lu, Zhengyu
    He, Yongqi
    Leng, Xin-Yu
    Meng, Xin
    Lei, Xiang
    Kong, Deyu
    Sun, Lulu
    Hu, Wenhao
    Yang, Yushe
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 21545 - 21567
  • [10] Discovery of GDC-0810 a novel, non-steroidal selective estrogen receptor degrader with robust activity in pre-clinical models of endocrine-resistant breast cancer
    Joseph, James
    Govek, Steven
    Darimont, Beatrice
    Brigham, Daniel
    Aparicio, Anna
    Bischoff, Eric
    Kahraman, Mehmet
    Nannini, Michelle
    Kaufman, Joshua
    Lai, Andily
    Lee, Kyoung-Jin
    Oeh, Jason
    Lu, Nhin
    Zhou, Wei
    Moon, Michael
    Qian, Jing
    Sensintaffar, John
    Shao, Gang
    Sampath, Deepak
    Friedman, Lori S.
    Rix, Peter
    Heyman, Richard A.
    Smith, Nicholas
    Hager, Jeffrey H.
    CANCER RESEARCH, 2015, 75